Keybank National Association Lantheus Holdings, Inc. Transaction History

Keybank National Association

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 27, 2022	SELL	$61.42 - $86.29 $58,103 - $81,630	-946 Reduced 24.46%	2,922 $206,000
Q2 2022 Aug 08, 2022	SELL	$55.54 - $72.65 $208,774 - $273,091	-3,759 Reduced 49.29%	3,868 $255,000
Q1 2022 Apr 28, 2022	SELL	$24.28 - $56.64 $52,226 - $121,832	-2,151 Reduced 22.0%	7,627 $422,000
Q4 2021 Feb 07, 2022	BUY	$22.54 - $30.44 $220,396 - $297,642	9,778 New	9,778 $282,000

540

68M

679K

423K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.14B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Keybank National Association, based on Form 13F filings with the SEC.

Stay updated on Keybank National Association with notifications on news.